Anesthesia Methods on Percutaneous Kyphoplasty
Evaluation of Anesthesia Methods in Patients Undergoing Percutaneous Kyphoplasty: A Prospective Study
1 other identifier
observational
66
1 country
1
Brief Summary
The aim of this research is to examine the effects of the anesthesia method and preoperative characteristics on postoperative results and complications in patients who underwent percutaneous kyphoplasty (PKP). Method: Patients were split into three groups according to anesthesia methods: (1) General Anesthesia (Sedation), (2) Central Block (Spinal and Epidural Anesthesia), (3) Peripheral Block \[Erector Spina Plane Block (ESPB), and Paravertebral Block (PVB)\]. Patients' pain values, hemodynamic parameters, additional need for sedation, and perioperative and postoperative complications were recorded prospectively together with Visual Pain Scales (VAS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 25, 2022
CompletedFirst Posted
Study publicly available on registry
September 2, 2022
CompletedSeptember 2, 2022
August 1, 2022
6 months
August 25, 2022
August 31, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Visual Analog Scala (VAS) values
VAS is a scala between 0-10 points. If there is no pain it means 0; very severe pain is 10 points.
VAS values at postoperative 24 hours
Secondary Outcomes (1)
Analgesic consumption
postoperative 24 hours after surgery
Study Arms (3)
Group 1
General anesthesia or sedation
Group 2
Central Block (Spinal and Epidural Anesthesia
Group 3
Peripheral Block \[Erector Spina Plane Block (ESPB), and Paravertebral Block (PVB)
Interventions
1 gr iv paracetamol for all patients with a VAS value of 2 or 3; for 4 and over, 1.5 mg/kg iv tramadol was administered additionally.
Eligibility Criteria
18-100 aged kyphoplasty patients
You may qualify if:
- ages kyphoplasty surgery patients
- written consent form received
You may not qualify if:
- The patient's unwillingness to participate in the study
- inability to communicate with the patient
- the patient does not speak Turkish,
- previous CVO, presence of cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bursa Training and Research Hospital
Bursa, 16600, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tuğba T Onur, MD
Bursa Yuksek Ihtisas Training and Research Hospital
- STUDY CHAIR
Ümran Ü Karaca, MD
Bursa Yuksek Ihtisas Training and Research Hospital
- STUDY CHAIR
Asiye A Demirel, MD
Bursa Yuksek Ihtisas Training and Research Hospital
- STUDY CHAIR
Şeyda Efsun ŞE Özgünay, Assoc Prof
Bursa Yuksek Ihtisas Training and Research Hospital
- STUDY CHAIR
Anıl A Onur, MD
Bursa Medicabil Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal İnvestigator
Study Record Dates
First Submitted
August 25, 2022
First Posted
September 2, 2022
Study Start
January 1, 2022
Primary Completion
July 1, 2022
Study Completion
August 1, 2022
Last Updated
September 2, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share
With the written consent of the patients and the approval of the ethics committee, I do not intend to share their special circumstances and information other than the study data.